Table 5. Stated origin and manufacturers of medicines, and compliance with USP 39 criteria.
| Stated origin | Stated manufacturer | Total samples | Non-compliant samples | % non-compliant | Extreme deviation | % extreme deviation |
|---|---|---|---|---|---|---|
| Togo | Tongmei | 15 | 0 | 0 | ||
| Sprukfield | 3 | 1 | 0 | |||
| total | 18 | 1 | 0 | |||
| Benin | Pharmaquick | 5 | 0 | 0 | ||
| Ghana | Letap | 3 | 0 | 0 | ||
| Nigeria | Nuel Pharma | 1 | 1 | 0 | ||
| Africa | 27 | 2 | 7% | 0 | 0% | |
| India | Lincoln Pharma | 6 | 1 | 0 | ||
| Alice | 1 | 0 | 0 | |||
| Cian | 1 | 1 | 0 | |||
| CIPLA | 1 | 0 | 0 | |||
| Fourrts | 1 | 0 | 0 | |||
| Medopharm | 1 | 0 | 0 | |||
| total | 11 | 2 | 0 | |||
| China | Greenfield | 1 | 0 | 0 | ||
| North China Pharmaceutical | 3 | 1 | 0 | |||
| Yangzhou NO.3 | 1 | 1 | 1 | |||
| total | 5 | 2 | 1 | |||
| Turkey | Billim | 1 | 0 | 0 | ||
| Asia | 17 | 4 | 24% | 1 | 6% | |
| France | Baily-Creat | 13 | 0 | 0 | ||
| GSK-France | 3 | 0 | 0 | |||
| Roche | 1 | 0 | 0 | |||
| total | 17 | 0 | 0 | |||
| Germany | Denk Pharma | 16 | 0 | 0 | ||
| Philco Pharma | 1 | 0 | 0 | |||
| total | 17 | 0 | 0 | |||
| Austria | Sandoz GmbH | 8 | 0 | 0 | ||
| Spain | Aldo-Union | 2 | 0 | 0 | ||
| Novartis | 2 | 1 | 0 | |||
| total | 4 | 1 | 0 | |||
| Italy | Bristol Myers Squibb | 1 | 0 | 0 | ||
| F.I.R.M.A S.p.A | 1 | 0 | 0 | |||
| total | 2 | 0 | 0 | |||
| Europe | 48 | 1 | 2% | 0 | 0% | |
| Total | 92 | 10 | 11% | 1 | 1% |